Where Does Aurora Cannabis Inc (ACB) Stock Fall in the Drug Manufacturers - Specialty & Generic Field?

Thursday, October 1, 2020 9:49 AM | InvestorsObserver Analysts

The 33 rating InvestorsObserver gives to Aurora Cannabis Inc (ACB) stock puts it near the middle of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 61 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, ACB’s 33 overall rating means the stock scores better than 33 percent of all stocks.

Overall Score - 33
ACB has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ACB!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 33 means the stock is more attractive than 33 percent of stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Aurora Cannabis Inc Stock Today?

Aurora Cannabis Inc (ACB) stock is trading at $4.58 as of 9:46 AM on Thursday, Oct 1, a drop of -$0.06, or -1.29% from the previous closing price of $4.64. The stock has traded between $4.58 and $4.70 so far today. Volume today is low. So far 224,897 shares have traded compared to average volume of 6,554,796 shares.

Click Here to get the full Stock Score Report on Aurora Cannabis Inc (ACB) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like